Fortress Biotech
FBIO
$1.70
Share price
2.10%
Change (1 day)
118.59%
Change (1 year)
Categories
Fortress Biotech (FBIO) - Total debt
Total debt on the balance sheet as of December 2023 : $84.66 M
According to Fortress Biotech 's latest financial reports the company's total debt is $84.66 M. A company’s total debt is the sum of all current and non-current debts.
Fortress Biotech - Total debt on balance sheet (from 2011 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 69.84% |
| 2021-12-31 | $74.97 M | -15.83% |
| 2020-12-31 | $89.07 M | -22.64% |
| 2019-12-31 | $0.11 B | 44.83% |
| 2018-12-31 | $79.5 M | 27.21% |
| 2017-12-31 | $62.49 M | 121.51% |
| 2016-12-31 | $28.21 M | 21.75% |
| 2015-12-31 | $23.17 M | 60.53% |
| 2014-12-31 | $14.43 M | 6.01% |
| 2013-12-31 | $13.61 M | -6.62% |
| 2012-12-31 | $14.58 M | 1844.4% |
| 2011-12-31 | $0.75 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | $12.63 M | -85.08% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Advaxis ADXS | $8.31 M | -90.18% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.25 B | 203.46% | 🇺🇸 USA |